Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Marathon Petroleum has moved from a stock where the Street was chasing the price to one where a meaningful subset of analysts is now ahead of it, and that shift in dynamic is the most interesting development of the past week.
Six days ago the consensus mean target was running well below the stock price. That gap has narrowed fast. Wells Fargo's Sam Margolin raised his target to $560 this week, from $400, while holding an Overweight rating. Citigroup followed with a lift to $518 from $318. Barclays moved to $488 from $321. Those three moves alone, all in the past three days, have done more to close the consensus gap than the preceding month of revisions. The mean target across the board now sits near $433, still below the $477 close on Tuesday, but the direction is unambiguous. Goldman Sachs sits at $472 with a Buy. Morgan Stanley is at $453 with Overweight. Jefferies remains the outlier, having downgraded to Hold in late September, a position that looks increasingly isolated as the stock adds another 10% on the week. The refiner's stock has now gained 20% in a month and the bull case, refining capture running above 108% through the first half of 2026, MPLX distributions covering parent dividends and capex, and a balance sheet carrying roughly 2% net debt to capital, is drawing real conviction from major houses.
Short positioning tells a quieter but slightly complicated story. At 2.4% of the free float, short interest is not a primary concern, but the week-on-week jump of 33% is worth noting. Shorts were near 5.2 million shares through most of early October and have since risen to 7.3 million. That said, the lending market is not remotely tight. Availability is extremely loose at 2,757%, meaning there are roughly 27 shares available to borrow for every one already lent out. Cost to borrow is just 0.36%, down 15% on the week. The short score of 33.7 sits comfortably in the lower half of the range. None of this reads as a building squeeze or a crowded short. More likely the short rebuild reflects some investors fading the rally into the October 27 earnings date rather than a structural bear case taking shape.
Options positioning leans cautiously defensive. The put/call ratio is running at 1.20, modestly above its 20-day average of 1.16, with a z-score below one. That is nowhere near extreme, but the PCR has been creeping up since mid-September when it was under 1.0. The highest reading of the past year was 1.25, hit on Monday. Options traders are buying more downside protection than they were six weeks ago, consistent with pre-earnings hedging ahead of a stock that has run hard. After its August print, MPC fell 3% on the day before recovering to gain nearly 10% over the following week. That pattern, an initial dip absorbed by the move into results, will be in focus again in less than two weeks.
The factor picture reinforces the bull case in several dimensions. EPS momentum over both 30 and 90 days ranks in the 95th to 96th percentile, exceptional by any measure. The dividend score ranks in the 92nd percentile, though the dividend history in the data is stale and the current yield at this price level is modest. On valuation, the EV/EBITDA multiple has compressed over the past month as the stock rallied: it has dropped by more than one full turn over 30 days to around 6.4x, which the bear case notes is still above the roughly 5.5x level on a 2027 basis where the stock looked cheap. Price-to-earnings at 8.4x and earnings yield near 12% are not stretched for a refiner generating this level of cash flow. The main risk the bears flag is unchanged: refining spreads are volatile, the spread of crude differentials can compress quickly, and the company's lowest first-quarter in a decade for unplanned downtime earlier in 2026 may not repeat.
The refining sector has moved broadly this week. Close peer VLO gained 8.9% on the week, PSX rose 8.5%, and DINO added nearly 12%. MPC's 10% weekly gain puts it roughly in line with the group rather than standing alone, which means the catalyst is sector-wide rather than company-specific. The watch into October 27 is whether MPC's superior refining capture and balance sheet flexibility justify a valuation premium to the peer group, and whether the latest round of analyst target lifts, several of which now sit above the current price, begin to attract fresh institutional demand ahead of the print.
See the live data behind this article on ORTEX.
Open MPC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
